Assam Reporter

Knee osteoarthritis Pipeline Analysis- Therapies and Development Insights, Analysis of the Clinical Trials and Key Companies- Bone Therapeutics, Sun Pharmaceutical, Nordic Bioscience

 Breaking News
  • No posts were found

Knee osteoarthritis Pipeline Analysis- Therapies and Development Insights, Analysis of the Clinical Trials and Key Companies- Bone Therapeutics, Sun Pharmaceutical, Nordic Bioscience

May 04
12:22 2022
The report comprises Knee Osteoarthritis pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Knee Osteoarthritis therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Knee Osteoarthritis pipeline products.

DelveInsight’s “Knee Osteoarthritis Pipeline Insight report provides comprehensive insights about key companies and pipeline drugs in the Knee Osteoarthritis pipeline landscapes. 

The report comprises Knee Osteoarthritis pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Knee Osteoarthritis therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Knee Osteoarthritis pipeline products.   

Some of the key takeaways from the Knee Osteoarthritis Pipeline Report:

  • Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as Bone Therapeutics, Sun Pharmaceutical, Nordic Bioscience, etc., are developing therapies for the treatment of Knee Osteoarthritis.
  • Emerging therapies such as GXCPC1, TA-004 intra-articular injection, and X0002 Spray, are expected to have a significant impact on the Knee Osteoarthritis market in the coming years.  

Knee Osteoarthritis Overview

Knee osteoarthritis (OA), also known as degenerative joint disease, is typically the result of wear and tear and progressive loss of articular cartilage. It is most common in the elderly and can be divided into two types, primary and secondary. Primary osteoarthritis is articular degeneration without any apparent underlying reason. Secondary osteoarthritis is the consequence of either an abnormal concentration of force across the joint as with post-traumatic causes or abnormal articular cartilage, such as rheumatoid arthritis (RA).

Knee osteoarthritis (OA) is closely associated with age, as radiographic evidence of OA occurs in most people by age 65 years and in more than 75% of people older than age 75 years. Although there are many associations and mechanisms that are not well understood, it has been reported that there is a higher prevalence of OA among older women. 

Request a sample for the Pipeline Report: https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight 

Knee Osteoarthritis Pipeline Therapies along with Key Players

Pipeline Therapies:

  • GXCPC1
  • TA-004 intra-articular injection
  • X0002 Spray

Key Companies:

  • Bone Therapeutics 
  • Jiangsu
  • XinChen-Techfields Pharma 
  • Nordic
  • Bioscience
  • Sun
  • Pharmaceutical

 Scope of Knee Osteoarthritis Pipeline Drug Insight

  • Coverage: Global 
  • Major Players: Bone Therapeutics, Sun Pharmaceutical, Nordic Bioscience, and others.
  • Pipeline Therapies: GXCPC1, TA-004 intra-articular injection, X0002 Spray, and others.

 

Table of Contents

1

Knee Osteoarthritis Report Introduction

2

Knee Osteoarthritis Executive Summary

3

Knee Osteoarthritis Overview

4

Knee Osteoarthritis- Analytical Perspective In-depth Commercial Assessment

5

Knee Osteoarthritis Pipeline Therapeutics

6

Knee Osteoarthritis Late Stage Products (Phase II/III)

7

Knee Osteoarthritis Mid Stage Products (Phase II)

8

Knee Osteoarthritis Early Stage Products (Phase I)

9

Knee Osteoarthritis Preclinical Stage Products

10

Knee Osteoarthritis Therapeutics Assessment

11

Knee Osteoarthritis Inactive Products

12

Company-University Collaborations (Licensing/Partnering) Analysis

13

Knee Osteoarthritis Key Companies

14

Knee Osteoarthritis Key Products

15

Knee Osteoarthritis Unmet Needs

16 

Knee Osteoarthritis Market Drivers and Barriers

17

Knee Osteoarthritis Future Perspectives and Conclusion

18

Knee Osteoarthritis Analyst Views

19

Appendix

20

About DelveInsight

 

Get a customized pipeline report @Knee Osteoarthritis Drugs Pipeline Report  

 

Related Reports:

Knee Osteoarthritis Market

DelveInsight’s ‘Knee Osteoarthritis-Market Insights, Epidemiology, and Market Forecast—2032’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), 

 

About DelveInsight

 DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com

Related Articles